This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Inflammatory markers in the serum on admission
Timeframe: On hospital day 1
Change in inflammatory markers in the serum
Timeframe: Through hospital admission, average of 4 weeks
Inflammatory markers in the CSF on admission
Timeframe: On hospital day 1
Change in inflammatory markers in the CSF
Timeframe: Through hospital admission, average of 4 weeks
Cerebral vasospasm
Timeframe: Through hospital admission, average of 4 weeks
Hydrocephalus
Timeframe: Through hospital admission, average of 4 weeks